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Running Title: CAM in Hospice and Palliative Care 
 
Abstract: 
Context. The aim of palliative care is to improve quality of life for patients with serious illnesses by treating 
their symptoms and adverse effects. Hospice care also aims for this for patients with a life expectancy of six 
months or less. When conventional therapies do not provide adequate symptom management or produce their 
own adverse effects, patients, families and caregivers may prefer complementary or alternative approaches in 
their care. 
Objectives. To evaluate the available evidence on the use of complementary or alternative medicine (CAM) in 
hospice and palliative care and to summarize their potential benefits.  
Methods. A defined search strategy was used in reviewing literature from major databases. Searches were 
conducted using base terms and the symptom in question. Symptoms included anxiety, pain, dyspnea, cough, 
fatigue, insomnia, nausea, and vomiting. Studies were selected for further evaluation based on relevancy and 
study type. References of systematic reviews were also assessed. After evaluation using quality assessment 
tools, findings were summarized and the review was structured based on PRISMA guidelines. 
Results. Out of 4682 studies, 17 were identified for further evaluation. Therapies included acupressure, 
acupuncture, aromatherapy massage, breathing, hypnotherapy, massage, meditation, music therapy, reflexology, 
and reiki.  Many studies demonstrated a short-term benefit in symptom improvement from baseline with CAM, 
although a significant benefit was not found between groups.  
Conclusion. CAM may provide a limited short-term benefit in patients with symptom burden. Additional 
studies are needed to clarify the potential value of CAM in the hospice or palliative setting. 
 
Keywords: Complementary therapy, alternative therapy, palliative care, hospice care, symptom management, 
review 
  
 
 
 
 
Introduction   
About one-third of American adults have reported use of complementary and alternative medicine 
(CAM) including mind and body practices, among many others.1,2 Despite increasing use, and many CAM 
therapies lack sufficient, high quality evidence to support their use in the prevention and treatment of diverse 
conditions.3 In addition, many health care professionals continue to have inadequate knowledge about CAM 
therapies. 
CAM therapies have been used in the palliative care and hospice settings for many years, especially in 
the United Kingdom. Patients in these settings commonly report a high symptom burden potentially affecting 
their quality of life. Distressing symptoms may be related both to the underlying disease, as well as adverse 
effects from treatment. As a result, when conventional therapies do not provide adequate symptom relief or 
produce additional adverse effects, patients, families, and caregivers may select CAM approaches, especially 
near the end of life.     
Data from the 2007 National Home and Hospice Care Survey revealed that CAM was offered by over 
40% of hospice care providers. About one-quarter of the surveyed patients received some form of a CAM 
therapy during hospice care. The therapies most commonly offered by hospice care providers included massage, 
supportive group therapy, and music therapy.4 The Hospice and Palliative Nurses Association (HPNA) has also 
recognized the prevalence and potential role of CAM in the palliative and hospice setting. The HPNA 
encourages the use of licensed and/or certified CAM services to provide holistic end-of-life care.5 
With increasing support for CAM, the need for more data on different practices has continued to grow. 
A 2000 systematic review assessed the effectiveness of CAM therapies on selected symptoms at end of life. The 
authors identified that acupuncture and massage, among others, may provide pain relief while patients with end 
stage chronic obstructive lung disease may have less dyspnea from using acupressure and muscle relaxation. 6 In 
the almost 20 years intervening, additional studies assessing the potential role of CAM therapies at the end of 
life have been published. The purpose of this systematic review was to identify and evaluate new evidence of 
 
 
 
 
CAM therapies in managing common symptoms and improving quality of life in the palliative and hospice 
setting.    
Methods   
Protocol and Registration 
The systematic review was conducted in accordance to the Preferred Reporting Items for Systematic 
Reviews and Meta-Analyses (PRISMA) statement and is registered in the International Prospective Register of 
Systematic Review (PROSPERO): CRD42017067375.7,8  
Literature Search 
A literature search was conducted in four databases including MEDLINE through PubMed, 
Cumulative Index to Nursing and Allied Health Literature (CINAHL), PsycINFO, and Embase, for studies 
which assessed the efficacy of a CAM therapy in a palliative or hospice setting. The initial search was focused 
on the common symptoms that patients would experience in this setting.  
Specific terms were used according to the database’s preferred terminology. Medical subject headings 
(MesH) terms, headings, thesaurus terms, and Emtree terms were used for PubMed, CINAHL,  PsycINFO, 
and Embase, respectively. The search consisted of three base terms, “complementary medicine”, “palliative 
care”, “hospice care”, and a specific symptom as a fourth term. “Complementary” was the preferred MeSH term 
in PubMed while “alternative” was preferred for Embase, PsycINFO, and CINAHL. Symptoms included 
“pain”, “nausea”, “vomiting”, “anxiety”, “cough”, “fatigue”, “insomnia”, and “dyspnea”.  All are commonly 
reported by patients receiving palliative care, with the majority of patients diagnosed with cancer.6,9 Filters for 
study types, date range of January 1999 to May 2016, and English language were applied after entering search 
terms to narrow results.    
A second search focused on CAM and quality of life at end of life was also conducted to include 
multiple symptoms and overall aspects of a patient’s life. In this search, the same initial base terms, 
 
 
 
 
“complementary medicine”, “palliative care”, “hospice care”, were used and the fourth term was “quality of 
life”. Table 1 provides an overview of the specific terms used and filters applied according to database.  
A third search was conducted using the same search terms and filters for date range and English 
language. However, rather than filter for controlled trials, a filter for systematic reviews was applied.  
Eligibility 
Each author screened results from one assigned database based on title and abstract. To be eligible 
for review, controlled trials had to assess the efficacy of a CAM therapy in managing a symptom or quality of 
life in patients in a palliative or hospice setting. Systematic reviews were screened using the same eligibility 
criteria. Once systematic reviews were identified, their references were screened for additional controlled trials 
and systematic reviews that met the inclusion criteria. References of these additional sources were also 
screened. Meeting abstracts and quasi-experimental studies were excluded and duplicates were also removed.  
Study Selection, Data Extraction, and Analysis 
After compiling the full-text articles, all authors independently assessed and scored them 
using the Jadad scale for controlled trials. Randomization, blinding, and accountability for study participants are 
all factors assessed in the Jadad scale, and account for selection bias, performance and detection bias, and 
attrition bias, respectively.10 Studies which received a Jadad score of three or greater were included. 
A meeting of the four authors was held to review Jadad scores. Disagreements were resolved by 
discussion of the studies and a consensus was subsequently reached. After finalizing selected articles, each 
author independently extracted the data which was subsequently verified by the other three authors. The study 
design, patient population, CAM intervention, duration of therapy, symptom(s) assessed, outcomes, 
measurement tools, and results were assessed. 
Of the 3705 unique records identified and screened, 86 full-text articles were analyzed in depth. Of 
these, 69 were excluded for reasons such as inappropriate study population, resulting in 17 eligible for inclusion 
(Figure 1).  
 
 
 
 
Results 
 Table 2 summarizes findings from the 17 included studies of CAM interventions in the palliative or 
hospice care setting. The studies which met our inclusion criteria assessed mind and body interventions. 
Symptoms assessed included pain, nausea and vomiting, dyspnea, anxiety and depression, and quality of life.  
Many studies tested for improvement in multiple symptoms, with pain most frequently assessed (n=8). 
Sixteen trials enrolled patients with advanced cancer with a few including patients with other diseases and one 
enrolling patients with HIV/AIDS. The visual analogue scale (VAS) and Rotterdam Symptom Checklist 
(RSCL) were the most commonly used measurement tools.  Assessment tools are described in Supplemental 
Table 1.  
Acupressure   
 One study assessed the efficacy of acupressure versus sham wristbands in reducing nausea and 
vomiting for three days.11 Measurements were recorded every 6 hours while wearing the wristbands. One 
patient reported mild swelling as an adverse event. Antiemetics were continued for participants, although the 
specific drug and administration time were not documented. The study was a pilot study and evidence of a 
difference between study groups was unlikely. The investigators suggested acupressure may be considered as an 
adjunct for palliative care patients in controlling nausea and vomiting. 
Acupuncture 
A pilot study evaluated the efficacy of electroacupuncture versus a palliative care nurse-led supportive 
care group for multiple symptoms based on the Edmonton Symptom Assessment Scale (ESAS).12 Acupuncture 
points were chosen based on specific symptoms of each patient. The supportive group involved a 20 to 30-
minute meeting with a palliative care nurse who provided counseling, emotional support, and coping strategies. 
Scores were recorded before and immediately after each intervention, and during weekly follow-ups. 
Acupuncture improved symptoms immediately after each session. yet ESAS scores increased by the 6-week 
follow-up. Right-leg stiffness and a “falling asleep” sensation were the only reported adverse effects.  Nurse-led 
 
 
 
 
supportive care improved symptom scores and benefit was seen at 6-week follow-up. Acupuncture may be 
feasible as a treatment for symptom reduction with immediate effects; however, its long-term benefits are 
uncertain.  
Breathing 
 A study compared the efficacy of one versus three sessions of a complex breathing intervention.13 
Participants reported a heavy breathlessness burden, defined by at least a score of 3 out of 10 on the Numerical 
Rating Scale (NRS). The group receiving three sessions had a worse baseline score in the mastery domain of the 
Chronic Respiratory Questionnaire – Self-Administered Survey (CRQ-SAS) while the other group had a worse 
baseline for anxiety. Breathing techniques included breathing training, anxiety management, relaxation, and 
pacing or prioritization. Secondary measures included variations of breathlessness reporting such as “average 
intensity”, “distress”, and “coping” using the NRS, CRQ-SAS, and HADS. A clinically significant 
improvement for worst breathlessness was seen; however, a “usual care” control arm was not included as a 
comparison for the intervention. The trial was well structured and replicable, which could warrant larger future 
studies.  
Hypnotherapy 
 Two studies assessed hypnotherapy in the palliative care and hospice setting. A crossover study 
compared hypnotherapy to standard care on pain measures.14 In addition to hypnotherapy sessions, participants 
were taught self-hypnosis to use between treatment sessions. Symptoms were rated using the MYMOP Version 
2 (MYMOP2) tool at baseline, week 4, and week 8. In addition to pain, effects on anxiety, insomnia, 
depression, headache, and desire to stop smoking were assessed. No study personnel confirmed the usage of 
proper technique or adherence to the assigned self-hypnosis, allowing for questions of the quality of the 
intervention. Because patients chose their most burdensome symptoms, multiple symptoms were evaluated; 
therefore, identifying the specific symptom(s) that hypnotherapy affects may be difficult. 
 
 
 
 
 A second study compared the effects of hypnotherapy to standard care on quality of life, anxiety, and 
depression.15 Patients rated their symptoms on their first visit and upon completion of the intervention. Missing 
RSCL subscale values were substituted using the personal scale mean of the respective respondent if at least 
50% of the items on the subscale were completed. Substituting incomplete data would affect the results and the 
true efficacy of the intervention would be unclear. Symptom management was conducted with medications and 
was not evaluated in depth. Therefore, the effect of hypnosis versus medications on symptoms remains unclear. 
Benefit was noted in the hypnosis group and supportive group which suggests that some form of cognitive 
intervention may assist patients at end of life with coping. 
Massage Therapy Alone  
 Seven studies have evaluated the efficacy of massage therapy; three were of massage therapy alone, 
three of massage combined with aromatherapy, and one assessed massage in combination with meditation.   
One study recruited 509 patients with 380 randomized to six 30-minute individualized massage sessions 
by a licensed massage therapist or simple touch.16 A similar proportion of patients in both groups previously 
received massage therapy; baseline pain scores were also similar between groups. Secondary measurements 
include the MPAC mood scale and the McGill Quality of Life Questionnaire. Scores were recorded at baseline, 
weeks 1 and 2, and 1.5 weeks after the intervention completion. Two serious adverse events were reported in 
the massage group (respiratory infection and gastrointestinal bleed), but were deemed unrelated to treatments. 
No control group was included which would have assisted in differentiating a true benefit from massage 
therapy. The study is notable because of its large, multisite design and shows some statistically significant 
immediate benefits with massage therapy. The short study period may have accounted for failure to detect a 
significant difference in sustained, longer term scores. 
A Spanish trial evaluated the effects of physical therapy, including massage and exercise, in patients 
with advanced cancer.17 Of 92 patients screened for eligibility, 24 were enrolled; three quarters were men and 
half had lung cancer. The intervention group received six physiotherapy sessions which consisted of several 
 
 
 
 
massage techniques, mobilization, and local and global exercises performed by a therapist. Pre- and post-
intervention scores assessed changes in pain while the mood portion of the MPAC and the Memorial Symptom 
Assessment Scale (MSAS) evaluated mood. Only 15 patients were assessed in the final analysis. Multiple 
techniques were implemented in the massage group and no standardized protocol was available for the trial to 
be replicated. Techniques were chosen according to the type of cancer, which may warrant further study into 
specific massage techniques to provide optimal symptom control. 
Another study compared a standardized massage or usual hospice care.18 During enrollment, none of the 
participants reported receiving massage therapy. All staff were blinded to subject group assignment except for 
the person who received eligibility forms and a social worker who scheduled the massage therapists. Although a 
standardized protocol for massage was created, sessions were still individualized and the duration varied from 
30 to 50 minutes. After the intervention, a few subjects reported receiving previous massage therapies prior to 
enrollment. Several subjects received additional massage sessions in between the study sessions. While the 
study did not report a significant difference with individuals receiving additional massages, the quality of the 
study intervention is questionable. The results may have been affected as a result of receiving more sessions and 
from an unknown source.  
Massage and Aromatherapy 
 A single-blinded study evaluated the long-term benefits of aromatherapy massage with lavender oil 
versus massage with an inert oil versus no massage.19 Enrollment fell short of the 15 patients needed in each 
study arm to detect a 2.3-point difference on the VAS.  Six patients withdrew as a result of death or feeling 
unwell. Groups were similar at baseline except the massage only group had a significantly higher RSCL score. 
Analyses were performed for the three study groups and an additional combined aromatherapy and massage 
group. The combined aromatherapy and massage group was not included as an initial study group to which 
participants were randomized. While not mentioned in the methodology section, results from the combined 
group were presented in the analysis; this is an important consideration when evaluating the analyses. 
 
 
 
 
  Another pilot study tested the feasibility of aromatherapy massage in patients with cancer. Of 46 
patients recruited from a palliative day care center, 29 completed the trial.20 The aromatherapy massage and 
control groups had similar mean performance status scores of 1.4 and 1.3, respectively. Six patients in the 
control group were taking antidepressants compared to none in the aromatherapy massage group. Adverse 
effects were limited to a rash following massage. A high withdrawal rate impacts assessment of the intervention 
and larger studies are needed.  
 Aromatherapy massage versus massage with an inert oil were compared for their effect on anxiety and 
quality of life.21 At baseline, patients randomized to aromatherapy reported poorer quality of life compared with 
those in the massage group. Quality of life (QoL) was measured at baseline and one week after the last massage 
was administered.  Anxiety scales were administered before and after each massage. Significantly greater 
improvement in RSCL subscales was noted for the aromatherapy group, despite a poorer baseline QoL. Further 
study into the specific essential oil used may be warranted to determine the impact on symptom improvement. 
No entry criteria were required for the study and a control group was not used. The lack of a control group is 
important as each modality has yet to be proven beneficial as individual treatments. 
Massage and Meditation  
A study evaluated both meditation and massage for improving QoL near end of life.22 A total of 106 
patients were screened with 58 randomized to one of four groups. Despite randomization, baseline 
characteristics in the study groups varied. The standard care group had higher mean viral load while the 
combined meditation and massage group had the highest CD4 count. Differences in baseline characteristics 
could affect the results of the interventions depending on patient health status. Responses were recorded at 
baseline, at the end of weeks 2 and 4 during the intervention period, and 1-month after the intervention (week 
8). The combined meditation and massage group demonstrated the greatest overall improvement even after 
multivariate adjustment for baseline differences. However, because the combined group had a higher CD4 count 
 
 
 
 
and a lower viral load at baseline, the results may reflect better participant disease control in comparison to the 
other groups.  
Music Therapy 
 A palliative care team analyzed 198 patients with advanced, life-limiting illness.23 The music therapy 
group received 20-minute music therapy sessions performed by a music therapist. Each music therapy session 
was individualized, although a standardized framework for the sessions was implemented. The control group 
received the same comfort measures as the music therapy group during the session; however, a music therapist 
was not present. Both groups had similar baseline characteristics. Pain was assessed at pre- and post-
intervention. Although 20 minutes was allotted, a few accounts of up to 50 minutes were noted. As a result, the 
timing of the post-intervention score also varied. Blinding was broken for a few patients because participants 
revealed their group assignment to the research assistant. Only immediate effects were studied, so the long-term 
benefits are unknown. 
 In an Australian study, 25 patients were recruited from inpatient hospice services.24 Only age, sex, and 
diagnosis were reported for baseline characteristics.  Music session length varied from 20-40 minutes and any 
sessions outside of the study’s session duration were not included in the data. Therefore, data could be missing 
that would affect the overall results. Only pre- and post-intervention scores were recorded so only short-term 
effects were assessed. Patients in the control group continued to receive music therapy outside of the study, 
making it unclear if the control group was a true control with no pre-exposure to music therapy. Both studies 
showed music therapy improved symptom burden; participants requested and continued receiving music 
therapy outside of the studies.  
Reflexology 
  Two studies assessed the efficacy of reflexology in improving QoL. One study randomized 12 patients 
receiving palliative care  to receive reflexology or placebo.25 Interventions were carried out on days 1, 3, and 5; 
assessments using the VAS were recorded at baseline and after the intervention. Multiple symptoms were 
 
 
 
 
assessed including appetite, breathing, communication, constipation, pain, and tiredness. Although the 
reflexologist could avoid reflexology points to simulate “placebo reflexology”, some skill may still remain in 
providing patients relief through a foot massage. Overall, patients reported an improvement in QoL, but with 
the short duration and small population, the generalizability of the study to other care centers is difficult. 
 In the second trial, patients who were not receiving active cancer treatment were recruited to receive 
reflexology or foot massage.26 Seventeen patients were included in the analysis. Participants and interviewers 
were blinded to the intervention. “Placebo” foot massage may have provided some level of relief for the 
patients. Neither group demonstrated significant improvement in mood and the study failed to demonstrate 
superiority of reflexology over foot massage. Foot discomfort was the predominant adverse effect, along with 
nausea, shaking, and sleep disturbances. Both studies used foot massage as a placebo”, but the benefit of 
massage alone may have occurred.  
Reiki 
 One trial assessed reiki for improvement in pain and QoL.27 Of 73 patients screened for eligibility, 
24were enrolled.  Participants received varying amounts of opioids, but were all considered to be opioid tolerant 
as defined by having a dose increase of over 5% per day. Eleven patients were taking less than 60 mg of 
morphine per day, eight received between 60-300 mg/day and five were taking over 300 mg/day. Primary 
outcome measures were assessed on days 1 and 4. Quality of life was assessed using ESAS. The use of 
objective outcome measures could provide more evidence if a placebo effect was present. Although no 
difference was found between the two groups, the study was practical because it also assessed conventional 
treatment. Reiki as an adjunct to opioid therapy warrants further study with a larger cohort and longer study 
period. 
Discussion 
 This systematic review of randomized controlled trials was conducted to evaluate the newer evidence 
available since the 2000 publication by Pan and colleagues.6 The older databases, CancerLIT and AIDS-LINE, 
 
 
 
 
have since been incorporated into MEDLINE, resulting in fewer and more comprehensive databases from 
which our searches were conducted.  No randomized controlled trials of herbal products or dietary supplements 
were identified in the literature search, resulting in the included studies evaluating mind and body CAM. Using 
the Jadad scale, we identified higher quality studies on CAM in the palliative or hospice setting.  
 Massage therapy, combined with aromatherapy, meditation, or massage alone, were the most common 
CAM assessed in our systematic review.  Studies that assessed massage therapy alone and massage combined 
with meditation demonstrated improvement in pain and QoL when compared to control. Mixed results were 
found in studies with massage with aromatherapy. Two studies reported no significant change in QoL or pain 
while the third aromatherapy massage study reported improvement in anxiety. A decrease in anxiety and pain 
was observed in patients who received music therapy, although blinding to intervention and additional therapy 
sessions were concerns. No difference in QoL or symptom improvement was seen in hypnotherapy trials. Of the 
other CAM, reiki produced a significant decrease in pain intensity although one study was underpowered. 
 This systematic review has several limitations. While we had defined CAM by the National Center for 
Complementary and Integrative Health’s definition, variations of the word exist. By exploding each database’s 
index terms, the number of terms under “Complementary therapies” or “Alternative therapies”, varied greatly as 
well as what was considered “CAM” (Supplemental Figure 1). Potential studies that did not list our index terms 
may have not populated in the search results. Our search strategy did not include the term integrative medicine 
which has been increasing in use to describe CAM. Excluding this term may have resulted in additional missed 
studies. 
 Our search terms included “palliative care” or “hospice care”. While those enrolled in hospice care 
receive palliative care, not all patients receiving palliative care may be near end of life. A few studies included 
patients enrolled in palliative care only and no specifications were stated on whether patients were still 
receiving active treatment. Therefore, the characteristics of the patient population may vary and affect how 
patients may feel or perform overall.  
 
 
 
 
The Jadad scale was used as the evaluation tool to decide which studies to include in the review. Despite 
the tool’s simplicity, our authors’ scores were inconsistent at times and differences were resolved through 
discussions involving all authors. The reasons for variability in Jadad scores included ambiguity of the studies 
and differing opinions. While all studies included scored a three or higher on the Jadad scale, many other 
characteristics differed between the articles. For example, one study enrolled a total of eight patients while 
another study enrolled 200 patients.11,23 
Various study designs were used and what was considered “control” or “placebo” differed among the 
studies. Depending on what one considers as “CAM”, the control group of a study may be considered another 
CAM. One such example is the reflexology study conducted by Hodgson et al in which the “placebo 
reflexology” was a gentle foot massage.26 In addition, by the nature of mind and body CAM, true blinding of 
the participants and performers is difficult. Some methods have been developed to provide blinding of CAM 
such as sham acupuncture. However, sham acupuncture has mixed results on its reliability as a placebo.28 We 
were unable to perform a meta-analysis as a result of the varying measurement tools used by the studies we 
evaluated. Additionally, the majority of measurement tools were subjective. A few studies used objective 
measurements, such as blood pressure or respiratory rate.20 Not all studies performed statistical analyses and 
one study that did reported failure to account for multiple testing.20 In addition, multiple studies assessed quality 
of life which encompasses multiple symptoms. As a result, determining what symptoms benefit most from a 
CAM intervention is difficult since multiple symptoms were evaluated simultaneously.  
Enrollment rates for studies were low despite recruitment periods of a few years in several studies.12 In 
addition, as a typical finding in the hospice care setting, many participants withdrew because of poor health or 
death. The high withdrawal rate further decreases the small population size and many studies were unable to 
provide power calculations to conclude any significance. Taking this into account, some studies had broader 
inclusion criteria to recruit as many participants as possible. However, in doing so, a diverse population in 
which treatments and demographic characteristics vary greatly among patients resulted. A few studies addressed 
 
 
 
 
concomitant use of drug therapy, but did not specify the drugs used or duration of drug therapy.11,13 Studies 
were conducted in multiple countries, such as the United Kingdom or Spain.18,21 The applicability of such 
studies should be taken into account as the patient population and treatment modalities may differ depending on 
the country. Baseline scores for patients’ reported symptoms also differed between study groups in several 
studies, which could affect the results of how well the intervention managed the symptom(s) in question. 
Although limitations are apparent, our review identified new studies which show a modest benefit in 
improvement of patients’ quality of life and symptoms. Despite few studies reporting statistically significant 
changes in symptom improvement, clinically significant changes were documented and patients reported 
positive outcomes in interviews and on questionnaires.  Adverse effects were uncommon and minor in nature. A 
professional in the specific CAM approach was recruited to perform the intervention in multiple studies. The 
expertise of the CAM provider is important to ensure the highest quality of CAM is given.  
We identified common outcome measures which may be considered for future studies. A possible meta-
analysis may be performed if new studies used the same measures. Our work has also identified barriers to 
CAM studies which may be taken into consideration, such the lack of a universal assessment tool or accepted 
placebo for proper assessment of a CAM. Small patient populations and short study periods are additional 
barriers to providing a higher quality study to demonstrate adequate power. A few studies simultaneously 
assessed multiple CAM modalities, making it difficult to identify which therapy provides more benefit. For 
patients who are interested in CAM, a discussion should be held with their healthcare providers about potential 
value and considerations. 
Conclusions 
Since 2000, additional studies evaluating CAM in the palliative and hospice setting have been published. 
This systematic review identified and evaluated pilot studies testing the feasibility of a CAM intervention in the 
palliative or hospice setting as well as larger trials of a previously tested CAM. Of the studies reviewed, a 
modest short-term benefit was observed in some trials. Future studies should consider a multicenter design to 
 
 
 
 
recruit more patients. One CAM modality should be assessed at a time and a universal tool for evaluating 
symptom improvement should be established for consistency. Of the CAM interventions summarized, music 
therapy, massage therapy, and reiki had  the most potential benefit although all studies had significant 
limitations. Continued research is essential to provide the best patient care in hospice and palliative care.  
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Table 1 
Summary of Search Strategies and Number of Results 
 
Database Search Terms Symptoms + “Quality of life” Applied Filters No. Resultsa 
 
MEDLINE (PubMed) 
 
((("Complementary Therapies"[Mesh]) 
AND ( "Hospice and Palliative Care 
Nursing"[Mesh] OR "Palliative 
Care"[Mesh] OR "Palliative 
Medicine"[Mesh] OR "Hospice 
Care"[Mesh])) AND "SYMPTOM"[Mesh]) 
 
"Pain"[Mesh] 
"Dyspnea"[Mesh] 
"Cough"[Mesh] 
"Nausea"[Mesh] 
"Vomiting"[Mesh] 
"Anxiety"[Mesh] 
"Sleep Initiation and Maintenance Disorders"[Mesh] 
"Fatigue"[Mesh] 
 
Study Types: 
Clinical study/trial 
Controlled clinical trial 
Randomized controlled trial 
Systematic reviews 
Meta-analysis 
Multicenter study 
Observational study 
 
Date:  
1999-2016 
 
 
140 
 
CINAHL 
 
(MH "Alternative Therapies+") AND ((MH 
"Palliative Care") OR (MH "Hospice and 
Palliative Nursing") OR (MH "Terminal 
Care") OR (MH "Hospice Care")) AND 
(MH “SYMPTOM”) 
 
(MH “Pain+”) 
(MH “Dyspnea”) 
(MH “Nausea+”) 
(MH “Nausea and Vomiting”) 
(MH “Vomiting”) 
(MH “Anxiety+”) 
(MH “Insomnia+”) 
(MH “Fatigue+”) 
 
Study Types: 
Clinical trial 
Meta-analysis 
Randomized controlled trial 
Research 
Systematic review 
 
Date: 
January 1999-May 2016 
 
 
197 
 
Embase 
 
'alternative medicine'/exp AND 'palliative 
therapy'/exp OR 'palliative nursing'/exp 
AND SYMPTOM/exp 
 
'pain'/exp 
'dyspnea'/exp 
'coughing'/exp NOT 'pertussis' NOT 'experimental coughing' 
'nausea'/exp 
'vomiting'/exp NOT 'experimental emesis' 
'anticipatory nausea and vomiting'/exp 
'chemotherapy induced emesis'/exp 
'chemotherapy induced nausea and vomiting'/exp 
 
Study Types: 
Clinical trial 
Prospective study 
Randomized controlled trial 
 
458 
 
 
 
 
'radiation induced emesis'/exp 
'nausea and vomiting'/mj 
‘anxiety'/exp 
‘insomnia'/exp 
'fatigue'/exp NOT 'persian gulf syndrome' NOT 'postviral 
fatigue syndrome' 
 
Systematic review 
Retrospective study 
 
Date: 
1999-2016  
 
PsycINFO 
 
SU.EXACT.EXPLODE("Alternative 
Medicine") AND 
SU.EXACT.EXPLODE("Palliative Care") 
OR SU.EXACT.EXPLODE("Hospice") 
AND 
SU.EXACT.EXPLODE("SYMPTOM") 
 
SU.EXACT.EXPLODE("Pain") 
SU.EXACT.EXPLODE("Dyspnea") 
SU.EXACT.EXPLODE("Nausea") 
SU.EXACT.EXPLODE("Vomiting") 
SU.EXACT.EXPLODE("Anxiety") 
SU.EXACT.EXPLODE("Insomnia") 
SU.EXACT.EXPLODE("Fatigue") 
 
 
Methodology: 
Follow-up study 
Meta-analysis 
Prospective study 
Systematic review 
Treatment outcome/clinical 
trial 
 
Date: 
After December 31, 1998- 
May 2016 
 
 
695 
 
Table 1. Summary of Search Strategies and Number of Results. This chart demonstrates the search strategy used, including search terms and filters used for each database and the number of 
results produced. Included terms are specific to their respective database. A separate search was conducted for each symptom listed. Not all databases included a symptom of interest (i.e. “Cough” was 
not a valid search term in CINAHL) 
a=With duplicates removed 
 
  
 
 
 
 
Table 2 
Summary of Articles Included in Systematic Review 
 
Primary 
Author 
(Year) 
Study Design Patient Populationa Interventions Duration of Study Primary 
Symptom(s) 
Assessed 
Primary Outcome Results 
Acupressure 
Perkins, P 
(2008) 
R, SB, C  • 8 patients with 
terminal cancer 
• Median age 61 
years (range 48-
74 years) 
• Acupressure 
wristbands  
(P6 pressure point) 
(n=3) 
• Sham wristbands 
(n=5) 
3 days • Nausea 
• Vomiting 
• VAS 
• Total antiemetic 
doses 
• Antiemetic 
escalation 
• Change in emesis 
episodes from 
baseline 
• No evidence of difference between 
two groups for any endpoint 
• SSC: 23, 15, and 15 patients needed 
in each group to show difference 
between change from baseline 
emesis, antiemetic doses, and VAS 
score 
Acupuncture 
Lim, JTW 
(2011) 
R, NB, C • 18 patients with 
incurable cancer  
• EG: mean age 
55 ± 11.1 years 
(range 31-72; 8 
women, 2 men) 
• CG: mean age 
64.9 ± 8.7 years 
(range 53-81; 7 
women, 1 man) 
• Acupuncture 
(n=10) 
• Nurse-led 
supportive care 
(n=8) 
4 weeks  
(weekly follow-up 
for 6 weeks after 
final intervention) 
• Pain 
• Tiredness 
• Nausea 
• Depression 
• Anxiety 
• Drowsiness 
• Loss of appetite 
• Lack of 
wellbeing 
• SOB 
• ESAS • Total ESAS scores were reduced by 
19% for EG (mean change -0.77 
[range -2.75 to 1.5]) and 26% for 
CG (mean change -1.69 [range -2.25 
to -0.25]) comparing baseline to 
week 6 after final intervention 
• Only descriptive statistics were used 
because of small sample size. 
Soden, K 
(2004) 
 
 
R, SB, C  • 42 patients with 
advanced cancer  
• Median age 73 
years (range 44-
85) 
• 32 women, 10 
men  
• Aromatherapy 
massage with 
lavender oil 
(n=16) 
• Massage with inert 
oil only (n=13) 
• No massage 
(n=13) 
4 weeks • Pain 
 
• VAS (primary 
endpoint) 
• Modified Tursky 
Pain Descriptors 
Scale  
• VSH 
• HADS 
• RSCL 
• No statistically significant changes 
in pain from baseline to end of study 
for any group   
• After second treatment, a reduction 
in pain VAS scores in both 
aromatherapy (P = 0.03) and 
combined massage (P = 0.01) was 
observed 
Wilcock, A 
(2004) 
R, NB, C • 29 patients with 
cancer  
• EG: mean age 
70 years 
• CG: mean age 
73 years 
• Aromatherapy 
massage with day 
care (n=11) 
• Day care only 
(n=18) 
4 weeks • QoL 
• Physical 
symptoms 
• Mood 
• MYMOP – Quality 
of Life 
• POMS – Mood 
• No statistically significant 
differences in outcomes between 
groups 
• Mean difference in slope for POMS 
total score  -0.4 (95% CI -3.4, 2.5) 
• Mean difference in slope for QoL 
-0.2 (95% CI -0.6, 0.2) 
 
 
 
 
Wilkinson, S 
(1999) 
R, NB, C • 87 patients with 
cancer 
• Mean age 53.5 
years 
• 78 women, 9 
men 
• Aromatherapy 
massage with 
Roman chamomile 
oil (n=43) 
• Massage with inert 
oil only (n=44) 
4 weeks • QoL 
• Anxiety 
• RSCL 
• STAI 
• Pre- and post-test scores for severe 
physical symptoms (P < 0.05), 
psychological (P < 0.001), and QoL 
(P < 0.01) with EG showed 
improvement 
• Pre- and post-test scores for anxiety 
were reduced in both groups (P < 
0.0001) 
Breathing 
Johnson, MJ 
(2015) 
R, NB, C • 124 patients with 
intrathoracic 
malignancy and 
breathlessnessb 
• One session: 
mean age 70 ± 9 
years 
• Three sessions: 
mean age 69 ± 
11 years 
• One breathing 
session (n=43) 
• Three breathing 
sessions (n=81) 
4 weeks 
(with a follow-up 
at 8 weeks) 
• Breathlessness • NRS (Worst 
breathlessness score) 
• Overall decrease in “worst score” 
from 6.81 ±1.89 at baseline to 5.84 
± 2.39 at week 4 
• No between arm differences in 
“worst breathlessness” NRS score 
between study groups; mean 
difference 0.2 (95% CI -2.31, 2.97) 
• SSC: 146 participants needed to 
determine difference in AUC for 
improvement of breathlessness 
Hypnotherapy 
Harlow, T 
(2015) 
R, NB, CS • 11 patients with a 
primary diagnosis 
of cancerb 
• Mean age 57 years 
• Hypnotherapy 
• Group A (n=9, 4 
weeks of 
hypnotherapy 
then 4 weeks off) 
• Group B (n=2, 4 
weeks off then 4 
weeks 
hypnotherapy) 
8 weeks • Pain • MYMOP (version 2) • No significant reduction in pain for 
patients who identified pain as 
primary symptom 
• SSC: 168 patients needed to detect a 
meaningful symptom change 
Liossi, C 
(2001) 
R, SB, C • 50 patients with 
advanced cancer  
• Age range 35-74 
years 
• Hypnotherapy 
with standard care 
(n=25) 
• Standard care only 
(n=25) 
4 weeks • QoL 
• Depression  
• Anxiety 
• RSCL 
• HADS 
• For both groups, post-intervention 
scores improved for all measured 
outcomes compared with baseline 
• HADS anxiety and depression 
scores decreased in the EG 
compared with CG (P<0.01) 
• RSCL subscales for psychological 
distress, physical distress, and 
activity level were improved for EG 
vs CG (P<0.01) 
Massage Therapy Only 
Kutner, JS 
(2008) 
R, SB, C • 380 patients with 
solid tumors and 
metastases 
• Massage therapy 
(n=188) 
• Simple touch 
(n=192) 
3 weeks • Pain • MPAC (Immediate 
pain) 
• BPI (Sustained pain) 
• MPAC scores showed clinically 
significant improved in massage 
group (-1.87 points [95% CI, -2.07,  
-1.67]) 
 
 
 
 
• EG: mean age 
65.2 ± 14.4 
years 
• CG: mean age 
64.2 ± 14.4 
years 
• EG superior to touch directly after 
treatment, but not clinically 
significant (mean pain difference -
0.90 points [95% CI, -1.19, -0.61]) 
• For BPI, no statistically or clinically 
significant difference between arms 
• SSC: 440, assuming 30% attrition, 
to detect clinically meaningful 
differences between study groups 
Lopez-
Sendin, N 
(2012) 
R, SB, C • 24 patients with 
terminal cancer  
• EG: mean age 
55 ± 21 years 
• CG: mean age 
54 ± 8 years 
• Physiotherapy 
(n=12) 
• Simple touch 
(n=12) 
2 weeks • Pain 
• Mood 
• MPAC (Pain and 
mood) 
• BPI (Sustained pain) 
• No significant group x time 
interaction for MPAC mood 
differences 
• Post-hoc analysis demonstrated 
potential improvements in worst and 
current pain 
• SSC: 12 subjects per group needed 
to detect difference in BPI score 
Wilkie, DJ 
(2000) 
R, SB, C  • 29 patients with 
cancerb 
• Mean age 63 
years (range 30-
87) 
• 20 men, 9 
women 
• Massage with 
hospice care 
(n=26) 
• Hospice care only 
(n=30) 
3 weeks • Pain 
• QoL 
• Pain Assessment 
Tool 
• Skilled Nursing 
Visiting Report 
Form 
• HR 
• RR 
• Graham QoL Tool 
• Some significant reductions in HR 
and RR after massage sessions 
• Reduced pain intensity immediately 
after 1st and 3rd massages (P<0.09) 
• Reduction in pain was not 
significant between study groups. 
• No significant differences between 
groups for QoL scores 
Massage and Aromatherapy 
Soden, K 
(2004) 
 
 
R, SB, C  • 42 patients with 
advanced cancer  
• Median age 73 
years (range 44-
85) 
• 32 women, 10 
men  
• Aromatherapy 
massage with 
lavender oil 
(n=16) 
• Massage with inert 
oil only (n=13) 
• No massage 
(n=13) 
4 weeks • Pain 
•  
• VAS (primary 
endpoint) 
• Modified Tursky 
Pain Descriptors 
Scale  
• VSH 
• HADS 
• RSCL 
• No statistically significant changes 
in pain from baseline to end of study 
for any group   
• After second treatment, a reduction 
in pain VAS scores in both 
aromatherapy (P = 0.03) and 
combined massage (P = 0.01) was 
observed 
Wilcock, A 
(2004) 
R, NB, C • 29 patients with 
cancer  
• EG: mean age 
70 years 
• CG: mean age 
73 years 
• Aromatherapy 
massage with day 
care (n=11) 
• Day care only 
(n=18) 
4 weeks • QoL 
• Physical 
symptoms 
• Mood 
• MYMOP – Quality 
of Life 
• POMS – Mood 
• No statistically significant 
differences in outcomes between 
groups 
• Mean difference in slope for POMS 
total score  -0.4 (95% CI -3.4, 2.5) 
• Mean difference in slope for QoL 
• -0.2 (95% CI -0.6, 0.2) 
Wilkinson, S 
(1999) 
R, NB, C • 87 patients with 
cancer 
• Aromatherapy 
massage with 
4 weeks • QoL 
• Anxiety 
• RSCL 
• STAI 
• Pre- and post-test scores for severe 
physical symptoms (P < 0.05), 
psychological (P < 0.001), and QoL 
 
 
 
 
• Mean age 53.5 
years 
• 78 women, 9 
men 
Roman chamomile 
oil (n=43) 
• Massage with inert 
oil only (n=44) 
(P < 0.01) with EG showed 
improvement 
• Pre- and post-test scores for anxiety 
were reduced in both groups (P < 
0.0001) 
Massage and Meditation  
Williams, A 
(2005) 
R, SB, C  • 58 patients with 
HIV/AIDS 
• Meditation: 
mean age 45.08 
± 2.2 years 
• Massage: mean 
age 42.81 ± 2.2 
years 
• Meditation and 
massage: mean 
age 47.31 ± 2.25 
years 
• Control: mean 
age 45.56 ± 2.24 
years 
• 43% women 
• Meditation only 
(n=13) 
• Massage therapy 
only (n=16) 
• Meditation and 
massage therapy 
(n=13) 
• Control (standard 
care) (n=16) 
8 weeks • QoL • MVQOLI • Combined group improvement for 
total score (3.75 ± 1.1 [P<0.05] and 
transcendent (5.92 ± 2.06 [P<0.05]) 
compared to other groups at 8 weeks 
• Function score improved in 
combined group (19.08 ± 5.48 
[P<0.05]) compared to massage and 
CG at 8 weeks 
• QoL improvements remained after 
multivariate adjustment for group 
differences at baseline 
• SSC: 40 subjects to detect a 5 point 
difference on MVQOLI between the 
combined and standard care groups  
Music Therapy 
Gutgsell, KJ 
(2013) 
R, SB, C • 200 patients with 
terminal illness 
• EG: mean age 
57.45 ± 14.76 
years 
• CG: mean age 
54.72 ± 15.34 
years 
• 69% women  
• Music therapy and 
comfort measures 
(n=100) 
• Comfort measures 
only (n=100) 
20-50 minutes  
(One music 
therapy session) 
• Pain • NRS • Decline (improvement) from pre- to 
post-test NRS for EG (mean change 
-1.94 [95% CI -2.37,  
-1.52]) and CG (mean change  
-0.56 [95% CI -0.92, -0.19]) 
• Greater decline in NRS score in the 
EG (difference in means -1.39 [95% 
CI -1.95, -0.83]) 
• SSC: 100 subjects per treatment arm 
to show differences in mean post-
test NRS 
Horne-
Thompson, A 
(2008) 
R, SB, C • 25 patients (24 
with cancer) 
• EG: mean age 
76.2 ±  10.36 
years 
• CG: mean age 
71.4 ± 16.05 
years 
• Music therapy 
(n=13) 
• Volunteer led 
therapy session 
without music 
(n=12) 
20-40 minutes  
(One music 
therapy session) 
• Anxiety • ESAS 
• HR 
• Anxiety using ESAS was reduced 
for EG (P=0.005), although post-
intervention data not reported 
• No difference between study groups 
for anxiety as demonstrated by 
decrease in HR (P=0.8) 
• SSC: 60 subjects to demonstrate a 
difference between groups 
Reflexology 
 
 
 
 
Hodgson, H 
(2000) 
R, SB, C • 12 patients with 
cancer  
• Age range 58-80 
years 
• Reflexology (n=6) 
• Gentle foot 
massage 
(“placebo” 
reflexology) (n=6) 
5 days • QoL • VAS • Breathing subscale of VAS 
improved with reflexology (mean 
change 2.2; P<0.05 between groups) 
• Overall improvement in QoL scores 
improved for EG (P=0.004 between 
groups; data not provided) 
Ross, CSK 
(2002) 
R, DB, C • 17 patients with 
advanced cancerb 
• Mean age 74 
years (range 57-
85) 
• 7 men, 10 women 
• Reflexology (n=7) 
• Simple foot 
massage (n=10) 
6 weeks • Mood  • HADS 
• Symptom Distress 
Score 
• HADS scores remained stable for 
both study groups from baseline to 
six weeks 
• No significant difference between 
groups except for improvement in 
appetite and mobility in foot 
massage group 
Reiki 
Olson, K 
(2003) 
R, NB, C • 24 patients with 
advanced cancerb 
• 79% solid 
tumors 
• 9 men; mean 
age 59.5 years 
• 15 women; 
mean age 56 
years 
• Reiki (n=11) 
• Rest (n=13) 
7 days • Pain 
 
• VAS 
• SBP/DBP 
• HR 
• RR 
• Improvement with EG reported for 
pain (P=0.035), drop in DBP 
(P=0.005) and HR (P=0.005) 
compared to rest on day one  
• No significant difference in pain or 
median morphine equivalent dose 
from day one to day seven between 
study groups 
• SSC: 100 subjects to detect a 20% 
reduction in VAS pain score 
 
Table 2. Summary of Articles Included in Systematic Review. This chart outlines characteristics of studies included in the systematic review. 
 
AUC=Area Under Curve. BPI=Brief Pain Inventory. C=Controlled. CG=Control Group. CS=Crossover Study. DB=Double Blinding. DBP=Diastolic Blood Pressure. EG=Experimental Group. 
ESAS=Edmonton Symptom Assessment Scale. HADS=Hospital Anxiety and Depression Scale. HIV/AIDS=Human Immunodeficiency Virus/Acquired Immunodeficiency Syndrome. HR=Heart 
Rate. MPAC=Memorial Pain Assessment Card. MSE=Mean Squared Errors. MVQOLI=Missoula-VITAS Quality of Life Index. MYMOP=Measure Your Medical Outcomes Profile Scores. NB=No 
Blinding. NRS=Numerical Rating Scale. POMS=Profile of Mood State. QoL=Quality of Life. R=Randomized. RR=Respiratory Rate. RSCL=Rotterdam Symptom Checklist. SBP=Systolic Blood 
Pressure. SOB=Shortness of Breath. SSC=Sample Size Calculation. SB=Single Blind. STAI=State Trait Anxiety Inventory. VAS=Visual Analog Scale. VSH=Verran and Snyder-Halpern sleep scale 
 
a=Baseline characteristics are listed as reported in study (i.e. Some studies analyzed characteristics of the whole study population while other studies analyzed characteristics of individual study 
groups) 
b=Number represents evaluable participants and does not include excluded participants originally randomized 
 
  
 
Supplemental Table 1 
Description of Validated Assessment Tools used in Studies 
 
Tool Use Subscales Scores 
ESAS1 Assess nine common 
symptoms experienced by 
patients receiving palliative 
care using VAS  
• Pain 
• Activity 
• Nausea 
• Depression 
• Anxiety 
• Drowsiness 
• Appetite  
• Wellbeing 
• Shortness of Breath 
• 0–100mm 
• 0 – Symptom is absent 
• 100 – Worst possible 
severity 
Higher numbers indicate worse 
outcomes  
Graham’s QoL Tool2 Measure perceived QoL in 
patients with melanoma 
• GWBS 
• CQLS 
• SCQLS 
 
GWBS: 
• 1–10 
• 1 – “poorer than most” 
• 10 – “very much better than 
most” 
CQLS 
• 1–10 
• 1 – Poor 
• 10 – Excellent  
SCQLS: 
• 1–10 
• 1 – Not at all satisfied 
• 10 – Very satisfied  
Lower numbers indicate worse 
outcomes 
 
 HADS3 Detect states of depression and 
anxiety in the setting of a 
hospital medical outpatient 
clinic 
• Anxiety 
• Depression 
 
Anxiety/Depression Subscales 
• 1–3 
• 1 – Not at all 
• 3 – Very often  
Overall: 
• 0–7 = Normal 
• 8–10 = Mild 
• 11–14 = Moderate 
• 15–21 = Severe 
Higher numbers indicate worse 
outcomes 
 
McGill QoL Questionnaire4 Assess QoL in patients with a 
life-threatening disease in a 
palliative care setting 
• Physical symptoms 
• Psychological symptoms 
• Existential wellbeing 
• Support 
 
• 0–10 
• 0 – Least desirable 
situation 
• 10 – Most desirable 
situation 
Lower numbers indicate worse 
outcomes 
 
 MYMOP/MYMOP25 Evaluate patient-generated 
measures over time  
• Symptom 1 
• Symptom 2 
• Activity 
 
• 0–6 
• 0 – As good as it could be 
• 6 – As bad as it could be 
Higher numbers indicate worse 
outcomes 
  
 
 MPAC6 Assess pain and distress in 
patients with cancer 
• Mood Scale 
• Pain Scale 
• Pain Description Scale 
• Relief Scale 
 
Mood Scale 
• Worst mood to Best mood 
Lower scores indicate worse 
outcomes 
 
Pain Scale 
• Least possible pain to Worst 
possible pain 
Higher numbers indicate worse 
outcomes 
 
Pain Description Scale 
• No pain 
• Weak 
• Mild 
• Just noticeable 
• Moderate 
• Strong 
• Severe 
• Excruciating 
Relief Scale 
• No relief of pain to Complete 
relief of pain 
Lower scores indicate worse 
outcomes 
 
 MSAS7 Evaluate symptom prevalence, 
characteristics, and distress in 
patients with cancer 
• Global Distress Index 
• MSAS Psychological 
• MSAS Physiological  
• 0–4 
• 0 – Not at all 
• 4 – Very 
severe/much/often 
Higher numbers indicate worse 
outcomes 
 
MVQOLI8 Assess QoL measures in 
patients with terminal illness 
• Global 
• Symptom 
• Function 
• Interpersonal 
• Wellbeing 
• Transcendent 
 
• Agree Strongly to 
Neutral/Disagree Strongly 
Outcome depends on statement to 
which answer is given 
NRS9 Measure severity of symptoms 
being assessed 
• None • 0 – # 
• 0 – Not at all 
• # – Worst  
Higher numbers indicate worse 
outcomes 
 
POMS10 Assess transient, fluctuating 
feelings and enduring affect 
states  
• TMD 
• Tension-anxiety 
• Depression 
• Anger-hostility 
• Vigor-activity 
• Fatigue 
TMD 
• 0–6 
• 0 – No disturbance 
• 76 – More disturbance 
 
  
 
• Confusion-bewilderment 
 
Higher numbers indicate worse 
outcomes 
 RSCL11 Assess QoL in patients with 
cancer 
• Physical Symptom Distress 
• Psychological Distress 
• Activity Level 
• Overall valuation of life 
 
Physical Symptom 
Distress/Psychological Distress 
• 1–4 
• 1 – Not at all 
• 4 – Very much 
Higher numbers indicate higher 
level of burden or impairment 
 
Activity Level 
• 1–4 
• 1 – Not at all 
• 4 – Very much 
Overall valuation of life 
• 1–7 
• 1 – Excellent 
• 7 – Very poor 
Higher numbers indicate worse 
outcomes 
 
STAI12 Measure presence and severity 
of current symptoms of 
anxiety 
• State Anxiety Inventory Scale 
• Trait Anxiety Inventory Scale 
 
State Anxiety Inventory Scale 
• 1–4 
• 1 – Not at all 
• 4 – Very much so 
 
Trait Anxiety Inventory Scale 
• 1–4 
• 1 – Almost never 
• 4 – Almost always 
Higher numbers indicate worse 
outcomes 
 
VAS13 Measure severity of 
symptom(s) being assessed 
• None 
 
• 0–100mm 
• 0 – Least possible  
• 100 – Worst possible 
 
Higher number indicates worse 
outcomes 
(Length of scale may vary) 
 
VSH14 Measure previous night’s sleep 
characteristics 
• Sleep Disturbance 
• Effectiveness 
• Supplementation 
 
Sleep Disturbance/Effectiveness 
• 0–100mm 
• 0 – Better sleep 
• 100 – Worse sleep 
 
  
 
Higher numbers indicate worse 
outcomes 
 
Supplementation 
• 0–100mm 
• 0 – Worse sleep 
• 100 – Better sleep 
 
Lower numbers indicate worse 
outcomes 
 
 
Table 2. Description of Validated Assessment Tools used in Studies. Table that describes various assessment tools that have been validated in 
literature. A few studies used tools specific to their institution which could not be found in literature or full access was unavailable. Variations of the 
listed tools may have been adopted in studies.  
CQLS=Current Quality of Life Scale. ESAS=Edmonton Symptom Assessment Scale. GWBS=Global Well Being Scale. HADS=Hospital Anxiety 
and Depression Scale. MYMOP/MYMOP2=Measure Your Medical Outcomes Profile (Version 2). MPAC=Memorial Pain Assessment Card. 
MSAS=Memorial Symptom Assessment Scale. MVQOLI=Missoula-VITAS Quality of Life Index. NRS=Numerical Rating Scale. POMS=Profile of 
Mood States. QoL=Quality of Life. RSCL=Rotterdam Symptom Checklist. SCQLS=Satisfaction with Current Quality of Life Scale. STAI=State-
Trait Anxiety Inventory Scale. TMD= Total Mood Disturbance. VAS=Visual Analogue Scale. VSH=Verran and Snyder-Halpern. 
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Figure 1. Flow Diagram of Steps in Systematic Review. Outlines steps taken and number of studies excluded and included in each step.  
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Supplemental Figure 1 
Complementary and/or Alternative Medicine Definitions 
Supplemental Figure 1. Complementary and/or Alternative Medicine Definitions. This figure provides examples of therapies according to each database’s definition of CAM. This table is not all-
inclusive. Includes MEDLINE’s Medical Subject Heading (MeSH) Definition of Complementary therapies, Embase’s Emtree Definition of Alternative therapies, PsycINFO’s Thesaurus Definition of 
Alternative therapies and Cumulative Index of Nursing and Allied Health Literature (CINAHL)’s Headings Definition of Complementary therapies.  
 
MEDLINE MeSH  
Complementary Therapies 
Acupuncture Therapy 
Acupuncture Analgesia 
Acupuncture, Ear 
Electroacupuncture 
Meridians + 
Moxibustion 
Anthroposophy 
Auriculotherapy (+1) 
Diffuse Noxious Inhibitory Control 
Holistic Health (+1) 
Homeopathy 
Horticultural Therapy 
Medicine, Traditional (+9) 
Mesotherapy 
Mind-Body Therapies 
Aromatherapy 
Biofeedback, Psychology + 
Breathing Exercises + 
Hypnosis + 
Imagery (Psychotherapy) 
Laughter Therapy 
Meditation 
Mental Healing 
Psychodrama + 
Psychophysiology 
Relaxation Therapy 
Tai Ji 
Therapeutic Touch 
Yoga 
Musculoskeletal Manipulations (+4) 
Therapy, Soft Tissue + 
Naturopathy 
Organotherapy (+1) 
Phytotherapy (+2) 
Reflexotherapy 
Sensory Art Therapies 
Acoustic Stimulation 
Aromatherapy 
Art Therapy 
Color Therapy 
Dance Therapy 
Music Therapy 
Play Therapy 
Speleotherapy 
Spiritual Therapies (+10) 
Embase Emtree 
Alternative Medicine 
Aromatherapy 
Horticultural therapy 
Iridology 
Mesotherapy 
Moxibustion 
Orthomolecular medicine 
Reiki 
Shamanism 
Spiritual healing 
Therapy with helminths 
 
 
PsycINFO Thesaurus 
Alternative Medicine 
Biofeedback Training 
Dietary Supplements 
Holistic Health 
Hypnotherapy 
Massage 
Medical Treatment (General) 
Medicinal Herbs and Plants 
Meditation 
Mind Body Therapy 
Osteopathic Medicine 
Phototherapy 
Physical Treatment Methods 
Preventive Medicine 
Shock Therapy 
Transcultural Psychiatry 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
CINAHL Headings 
 Alternative Therapies 
Alternative Medical Systems (+3) 
  Acupuncture (+4) 
   Meridians 
  Anthroposophy 
  Chiropractic (+1) 
  Homeopathy 
  Medicine, Herbal (+1) 
  Medicine, Oriental (+7) 
   Medicine, Ayurvedic 
   Medicine, Oriental  
    Acupressure (+2) 
    Medicine, Chinese (+3) 
     Acupuncture (+4) 
  Naturopathy 
 Apitherapy 
 Aromatherapy 
 Auriculotherapy (+1) 
 Bioelectromagnetic Application (+9) 
 Bioenergy Therapies  
  Reiki 
  Therapeutic Touch 
 Bowen Technique 
 Butekyo Method 
 Detoxification, Alternative Therapy (+2) 
 Life Style Changes 
 Manual Therapy (+4) 
  Chiropractic (+5) 
Massage (+5) 
  Reflexology  
 Mind Body Techniques 
  Guided Imagery 
  Hypnosis (+1) 
  Meditation 
  Music Therapy 
  Relaxation Techniques (+2) 
  Spiritual Healing (+1) 
  Tai Chi 
  Yoga (+1) 
Natural and Biologically Based Therapies (+2) 
 Medicine, Herbal 
 Pharmacological and Biological Treatments 
Rejuvenation 
Wilderness Experience 
 
